Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers

Abstract

Cancer cells frequently express genes normally active in male germ cells. ATAD2 is one of them encoding a conserved factor harbouring an AAA type ATPase domain and a bromodomain. We show here that ATAD2 is highly expressed in testis as well as in many cancers of different origins and that its high expression is a strong predictor of rapid mortality in lung and breast cancers. These observations suggest that ATAD2 acts on upstream and basic cellular processes to enhance oncogenesis in a variety of unrelated cell types. Accordingly, our functional studies show that ATAD2 controls chromatin dynamics, genome transcriptional activities and apoptotic cell response. We could also highlight some of the important intrinsic properties of its two regulatory domains, including a functional cross-talk between the AAA ATPase domain and the bromodomain. Altogether, these data indicate that ATAD2 overexpression in somatic cells, by acting on basic properties of chromatin, may contribute to malignant transformation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Boussouar F, Rousseaux S, Khochbin S . (2008). A new insight into male genome reprogramming by histone variants and histone code. Cell Cycle 7: 3499–3502.

    Article  CAS  PubMed  Google Scholar 

  • Ciro M, Prosperini E, Quarto M, Grazini U, Walfridsson J, McBlane F et al. (2009). ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors. Cancer Res 69: 8491–8498.

    Article  CAS  PubMed  Google Scholar 

  • Col E, Caron C, Chable-Bessia C, Legube G, Gazzeri S, Komatsu Y et al. (2005). HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses. EMBO J 24: 2634–2645.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • De Koning L, Savignoni A, Boumendil C, Rehman H, Asselain B, Sastre-Garau X et al. (2009). Heterochromatin protein 1alpha: a hallmark of cell proliferation relevant to clinical oncology. EMBO Mol Med 1: 178–191.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fillingham J, Kainth P, Lambert JP, van Bakel H, Tsui K, Pena-Castillo L et al. (2009). Two-color cell array screen reveals interdependent roles for histone chaperones and a chromatin boundary regulator in histone gene repression. Mol Cell 35: 340–351.

    Article  CAS  PubMed  Google Scholar 

  • Gradolatto A, Rogers RS, Lavender H, Taverna SD, Allis CD, Aitchison JD et al. (2008). Saccharomyces cerevisiae Yta7 regulates histone gene expression. Genetics 179: 291–304.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hartman HB, Yu J, Alenghat T, Ishizuka T, Lazar MA . (2005). The histone-binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3. EMBO Rep 6: 445–451.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jambunathan N, Martinez AW, Robert EC, Agochukwu NB, Ibos ME, Dugas SL et al. (2005). Multiple bromodomain genes are involved in restricting the spread of heterochromatic silencing at the Saccharomyces cerevisiae HMR-tRNA boundary. Genetics 171: 913–922.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ladurner AG, Inouye C, Jain R, Tjian R . (2003). Bromodomains mediate an acetyl-histone encoded antisilencing function at heterochromatin boundaries. Mol Cell 11: 365–376.

    Article  CAS  PubMed  Google Scholar 

  • Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H et al. (2008). Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359: 2313–2323.

    Article  CAS  PubMed  Google Scholar 

  • Perche PY, Vourc'h C, Konecny L, Souchier C, Robert-Nicoud M, Dimitrov S et al. (2000). Higher concentrations of histone macroH2A in the Barr body are correlated with higher nucleosome density. Curr Biol 10: 1531–1534.

    Article  CAS  PubMed  Google Scholar 

  • Pivot-Pajot C, Caron C, Govin J, Vion A, Rousseaux S, Khochbin S . (2003). Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein. Mol Cell Biol 23: 5354–5365.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rousseaux S, Khochbin S . (2009). New hypotheses for large-scale epigenome alterations in somatic cancer cells: a role for male germ-cell-specific regulators. Epigenomics 1: 153–161.

    Article  CAS  PubMed  Google Scholar 

  • Rubin DM, Glickman MH, Larsen CN, Dhruvakumar S, Finley D . (1998). Active site mutants in the six regulatory particle ATPases reveal multiple roles for ATP in the proteasome. EMBO J 17: 4909–4919.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sobel RE, Cook RG, Perry CA, Annunziato AT, Allis CD . (1995). Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4. Proc Natl Acad Sci USA 92: 1237–1241.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sung P, Higgins D, Prakash L, Prakash S . (1988). Mutation of lysine-48 to arginine in the yeast RAD3 protein abolishes its ATPase and DNA helicase activities but not the ability to bind ATP. EMBO J 7: 3263–3269.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tackett AJ, Dilworth DJ, Davey MJ, O'Donnell M, Aitchison JD, Rout MP et al. (2005). Proteomic and genomic characterization of chromatin complexes at a boundary. J Cell Biol 169: 35–47.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tseng RJ, Armstrong KR, Wang X, Chamberlin HM . (2007). The bromodomain protein LEX-1 acts with TAM-1 to modulate gene expression in C.elegans. Mol Genet Genomics 278: 507–518.

    Article  CAS  PubMed  Google Scholar 

  • Yu J, Li Y, Ishizuka T, Guenther MG, Lazar MA . (2003). A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation. EMBO J 22: 3403–3410.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zou JX, Guo L, Revenko AS, Tepper CG, Gemo AT, Kung HJ et al. (2009). Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer. Cancer Res 69: 3339–3346.

    Article  CAS  PubMed  Google Scholar 

  • Zou JX, Revenko AS, Li LB, Gemo AT, Chen HW . (2007). ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification. Proc Natl Acad Sci USA 104: 18067–18072.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by the ‘ANR blanc-Episperm’, INCa-DHOS’ and ‘ARC-ARECA’ research programs. CL and SM are supported by the PhD fellowship program of Région Rhône-Alpes and the post-doc fellowship program of INCa (AO 2006), respectively. AD salary is paid by the INCa–DHOS funds. Transcriptomic analyses of lung cancer patients were obtained thanks to the Ligue Contre le Cancer ‘Carte d’identité des Tumeurs’ (CIT) program. We acknowledge the support of the Nice-Sophia Antipolis Transcriptome Platform of the Marseille–Nice Genopole, in which the microarray experiments were carried out. Special thanks are due to Géraldine Rios for microarray production. We also acknowledge the support of the microscopy platform, Albert Bonniot Institute, Grenoble, and thank Catherine Souchier for her precious help in the FRAP experiments.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to C Caron or S Khochbin.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caron, C., Lestrat, C., Marsal, S. et al. Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers. Oncogene 29, 5171–5181 (2010). https://doi.org/10.1038/onc.2010.259

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.259

Keywords

This article is cited by

Search

Quick links